 |
ISBN
| 9781108479448 | |
DDC
| 610.68 | |
Nhan đề
| The business of healthcare innovation / Lawton R. Burns (editor) | |
Lần xuất bản
| 3rd ed. | |
Thông tin xuất bản
| Cambridge, United Kingdom : Cambridge University Press, 2020 | |
Mô tả vật lý
| 594 pages. ; cm. | |
Phụ chú
| Includes index. | |
Tóm tắt
| Perhaps as never before, countries around the world are looking at biomedical innovation as a source of (a) knowledge creation by their scientific communities, (b) value creation for their populations, and (c) wealth creation by fostering industries and expansion of employment. In the U.S., for example, bipartisan passage of the 21st Century Cures Act of 2016 seeks to accelerate new product development and faster patient access to new treatments and therapies. It also elevates the role of biomedical research through an additional $6.3 billion in funding for the National Institutes of Health (NIH) and other agencies | |
Từ khóa tự do
| Health economics | |
Từ khóa tự do
| Biotechnology business | |
Từ khóa tự do
| Health services management | |
Từ khóa tự do
| Healthcare innovation | |
Từ khóa tự do
| Medical technology industry | |
Khoa
| Khoa Khoa học Ứng dụng và Công nghệ | |
Tác giả(bs) CN
| Burns, Lawton R. | |
Địa chỉ
| Thư Viện Đại học Nguyễn Tất Thành |
| |
000
| 00000nam#a2200000u##4500 |
|---|
| 001 | 56991 |
|---|
| 002 | 2 |
|---|
| 004 | 7F798371-CBE8-4A0F-B044-018C145FE26F |
|---|
| 005 | 202509091400 |
|---|
| 008 | 250909s2020 xxk eng |
|---|
| 009 | 1 0 |
|---|
| 020 | |a9781108479448 |
|---|
| 039 | |a20250909140034|bquyennt|y20250909134924|zquyennt |
|---|
| 040 | |aNTT |
|---|
| 041 | |aeng |
|---|
| 044 | |axxk |
|---|
| 082 | |a610.68|bB9792|223 |
|---|
| 245 | |aThe business of healthcare innovation / |cLawton R. Burns (editor) |
|---|
| 250 | |a3rd ed. |
|---|
| 260 | |aCambridge, United Kingdom : |bCambridge University Press, |c2020 |
|---|
| 300 | |a594 pages. ; |ccm. |
|---|
| 500 | |aIncludes index. |
|---|
| 520 | |aPerhaps as never before, countries around the world are looking at biomedical innovation as a source of (a) knowledge creation by their scientific communities, (b) value creation for their populations, and (c) wealth creation by fostering industries and expansion of employment. In the U.S., for example, bipartisan passage of the 21st Century Cures Act of 2016 seeks to accelerate new product development and faster patient access to new treatments and therapies. It also elevates the role of biomedical research through an additional $6.3 billion in funding for the National Institutes of Health (NIH) and other agencies |
|---|
| 653 | |aHealth economics |
|---|
| 653 | |aBiotechnology business |
|---|
| 653 | |aHealth services management |
|---|
| 653 | |aHealthcare innovation |
|---|
| 653 | |aMedical technology industry |
|---|
| 690 | |aKhoa Khoa học Ứng dụng và Công nghệ |
|---|
| 691 | |aKhoa học Y sinh - Thẩm mỹ |
|---|
| 700 | |aBurns, Lawton R.|eeditor |
|---|
| 852 | |aThư Viện Đại học Nguyễn Tất Thành |
|---|
| 856 | 1|uhttp://elib.ntt.edu.vn/documentdata01/2 tailieuthamkhao/600 congnghe/biasach_2025/56991_thebusinessofhealthcareinnovationthumbimage.jpg |
|---|
| 890 | |a0|b0|c1|d0 |
|---|
| |
Không tìm thấy biểu ghi nào
|
|
|
|